Healthcare Global Enterprises Limited has informed the Exchange about earnings call of the Company scheduled on August 04, 2025, at 10.00 am to discuss the unaudited financial results for the quarter ended June 30, 2025.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has informed stock exchanges that it will hold an earnings conference call on Monday, August 4, 2025, at 10:00 am IST to discuss its unaudited financial results for Q1FY26 (quarter ended June 30, 2025). This follows the earlier intimation that the Board of Directors will meet on Friday, August 1, 2025, to approve and take on record the standalone and consolidated unaudited financial results. The call will be hosted by Strategic Growth Advisors and will feature participation from Chairman Dr. B S Ajaikumar, CEO Dr. Manish Mattoo, CFO Ms. Ruby Ritolia, and other senior management members. Dial-in details have been shared for investors in India, US, UK, Singapore, and Hong Kong. The filing is made under SEBI LODR Regulation 30, Part A of Schedule III.
This is a routine procedural disclosure with no direct impact on stock price, but it confirms that Q1FY26 results will be declared shortly (board meeting Aug 1, analyst call Aug 4). Investors should watch for revenue growth, margin trends, and patient volume commentary from the HCG management team during the call.